205 related articles for article (PubMed ID: 19197322)
1. INGN 007, an oncolytic adenovirus vector, replicates in Syrian hamsters but not mice: comparison of biodistribution studies.
Ying B; Toth K; Spencer JF; Meyer J; Tollefson AE; Patra D; Dhar D; Shashkova EV; Kuppuswamy M; Doronin K; Thomas MA; Zumstein LA; Wold WS; Lichtenstein DL
Cancer Gene Ther; 2009 Aug; 16(8):625-37. PubMed ID: 19197322
[TBL] [Abstract][Full Text] [Related]
2. An acute toxicology study with INGN 007, an oncolytic adenovirus vector, in mice and permissive Syrian hamsters; comparisons with wild-type Ad5 and a replication-defective adenovirus vector.
Lichtenstein DL; Spencer JF; Doronin K; Patra D; Meyer JM; Shashkova EV; Kuppuswamy M; Dhar D; Thomas MA; Tollefson AE; Zumstein LA; Wold WS; Toth K
Cancer Gene Ther; 2009 Aug; 16(8):644-54. PubMed ID: 19197324
[TBL] [Abstract][Full Text] [Related]
3. Effect of preexisting immunity on oncolytic adenovirus vector INGN 007 antitumor efficacy in immunocompetent and immunosuppressed Syrian hamsters.
Dhar D; Spencer JF; Toth K; Wold WS
J Virol; 2009 Mar; 83(5):2130-9. PubMed ID: 19073718
[TBL] [Abstract][Full Text] [Related]
4. New pancreatic carcinoma model for studying oncolytic adenoviruses in the permissive Syrian hamster.
Spencer JF; Sagartz JE; Wold WS; Toth K
Cancer Gene Ther; 2009 Dec; 16(12):912-22. PubMed ID: 19478829
[TBL] [Abstract][Full Text] [Related]
5. Syrian hamster tumor model to study oncolytic Ad5-based vectors.
Dhar D; Toth K; Wold WS
Methods Mol Biol; 2012; 797():53-63. PubMed ID: 21948468
[TBL] [Abstract][Full Text] [Related]
6. Use of the Syrian hamster as an animal model for oncolytic adenovirus vectors.
Thomas MA; Spencer JF; Wold WS
Methods Mol Med; 2007; 130():169-83. PubMed ID: 17401172
[TBL] [Abstract][Full Text] [Related]
7. Pre-existing immunity and passive immunity to adenovirus 5 prevents toxicity caused by an oncolytic adenovirus vector in the Syrian hamster model.
Dhar D; Spencer JF; Toth K; Wold WS
Mol Ther; 2009 Oct; 17(10):1724-32. PubMed ID: 19602998
[TBL] [Abstract][Full Text] [Related]
8. A fully replication-competent adenovirus vector with enhanced oncolytic properties.
Toth K; Kuppuswamy M; Shashkova EV; Spencer JF; Wold WS
Cancer Gene Ther; 2010 Nov; 17(11):761-70. PubMed ID: 20596091
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution of an oncolytic adenovirus after intracranial injection in permissive animals: a comparative study of Syrian hamsters and cotton rats.
Sonabend AM; Ulasov IV; Han Y; Rolle CE; Nandi S; Cao D; Tyler MA; Lesniak MS
Cancer Gene Ther; 2009 Apr; 16(4):362-72. PubMed ID: 19011597
[TBL] [Abstract][Full Text] [Related]
10. Cycles of transient high-dose cyclophosphamide administration and intratumoral oncolytic adenovirus vector injection for long-term tumor suppression in Syrian hamsters.
Dhar D; Toth K; Wold WS
Cancer Gene Ther; 2014 Apr; 21(4):171-8. PubMed ID: 24722357
[TBL] [Abstract][Full Text] [Related]
11. Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.
Thomas MA; Spencer JF; La Regina MC; Dhar D; Tollefson AE; Toth K; Wold WS
Cancer Res; 2006 Feb; 66(3):1270-6. PubMed ID: 16452178
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse.
Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO
Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942
[TBL] [Abstract][Full Text] [Related]
13. Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Clubb JHA; Kudling TV; Girych M; Haybout L; Pakola S; Hamdan F; Cervera-Carrascon V; Hemmes A; Grönberg-Vähä-Koskela S; Santos JM; Quixabeira DCA; Basnet S; Heiniö C; Arias V; Jirovec E; Kaptan S; Havunen R; Sorsa S; Erikat A; Schwartz J; Anttila M; Aro K; Viitala T; Vattulainen I; Cerullo V; Kanerva A; Hemminki A
Front Immunol; 2023; 14():1060540. PubMed ID: 36817448
[TBL] [Abstract][Full Text] [Related]
14. The effects of radiation on antitumor efficacy of an oncolytic adenovirus vector in the Syrian hamster model.
Young BA; Spencer JF; Ying B; Toth K; Wold WS
Cancer Gene Ther; 2013 Sep; 20(9):531-7. PubMed ID: 23928730
[TBL] [Abstract][Full Text] [Related]
15. The role of cyclophosphamide in enhancing antitumor efficacy of an adenovirus oncolytic vector in subcutaneous Syrian hamster tumors.
Young BA; Spencer JF; Ying B; Tollefson AE; Toth K; Wold WS
Cancer Gene Ther; 2013 Sep; 20(9):521-30. PubMed ID: 23928731
[TBL] [Abstract][Full Text] [Related]
16. Chapter three--Syrian hamster as an animal model to study oncolytic adenoviruses and to evaluate the efficacy of antiviral compounds.
Wold WS; Toth K
Adv Cancer Res; 2012; 115():69-92. PubMed ID: 23021242
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
[TBL] [Abstract][Full Text] [Related]
18. Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species.
Jogler C; Hoffmann D; Theegarten D; Grunwald T; Uberla K; Wildner O
J Virol; 2006 Apr; 80(7):3549-58. PubMed ID: 16537623
[TBL] [Abstract][Full Text] [Related]
19. Single dose GLP toxicity and biodistribution study of a conditionally replicative adenovirus vector, CRAd-S-pk7, administered by intracerebral injection to Syrian hamsters.
Kim JW; Auffinger B; Spencer DA; Miska J; Chang AL; Kane JR; Young JS; Kanojia D; Qiao J; Mann JF; Zhang L; Wu M; Ahmed AU; Aboody KS; Strong TV; Hébert CD; Lesniak MS
J Transl Med; 2016 May; 14(1):134. PubMed ID: 27184224
[TBL] [Abstract][Full Text] [Related]
20. Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses.
Koodie L; Robertson MG; Chandrashekar M; Ruth G; Dunning M; Bianco RW; Davydova J
Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30744019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
